Physician profile

Gregory A Imperi

Interventional Cardiology · Gainesville, FL

NPI 1710912621

$1,444.84

in general payments reported to CMS, 2019-2025

18 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $328.18 2019-2020
Amgen INC. $174.49 2019
Abiomed $136.19 2019
Medtronic, INC. $133.60 2022
W. L. Gore & Associates, INC. $110.93 2019
Abbott Laboratories $106.58 2021
Celonova Biosciences, INC. $100.00 2019
Acist Medical Systems, INC. $66.06 2019
Pfizer INC. $51.87 2019
Novartis Pharmaceuticals Corporation $41.84 2019
Astrazeneca Pharmaceuticals LP $41.20 2019
Astellas Pharma US INC $31.63 2019
Boehringer Ingelheim Pharmaceuticals, INC. $28.81 2019
Sanofi-Aventis U.S. LLC $27.93 2019
Medtronic Vascular, INC. $18.70 2019
Show all 18 companies
CompanyGeneral paymentsYearsTop products
Janssen Pharmaceuticals, INC $17.08 2019
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $15.68 2019
Smith+Nephew, INC. $14.07 2019

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Gregory A Imperi

$1,444.84

in general payments reported 2019-2025

Years
2019-2022
Top company
Boston Scientific Corporation

https://glasscript.com/doctor/77116/gregory-a-imperi

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.